BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22105841)

  • 1. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
    Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
    Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study.
    Thomassin-Naggara I; Soualhi N; Balvay D; Darai E; Cuenod CA
    J Magn Reson Imaging; 2017 Dec; 46(6):1776-1785. PubMed ID: 28370815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.
    Bernardin L; Dilks P; Liyanage S; Miquel ME; Sahdev A; Rockall A
    Eur Radiol; 2012 Apr; 22(4):880-90. PubMed ID: 22095438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiquantitative dynamic contrast-enhanced MRI for accurate classification of complex adnexal masses.
    Kazerooni AF; Malek M; Haghighatkhah H; Parviz S; Nabil M; Torbati L; Assili S; Saligheh Rad H; Gity M
    J Magn Reson Imaging; 2017 Feb; 45(2):418-427. PubMed ID: 27367786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses.
    Tang YZ; Benardin L; Booth TC; Miquel ME; Dilks P; Sahdev A; Rockall AG
    Br J Radiol; 2014 Nov; 87(1043):20130730. PubMed ID: 25237836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?
    Mansour SM; Saraya S; El-Faissal Y
    Br J Radiol; 2015 Sep; 88(1053):20150099. PubMed ID: 26083260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
    Yuan Y; Kuai XP; Chen XS; Tao XF
    Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative multiparametric MRI of ovarian cancer.
    Carter JS; Koopmeiners JS; Kuehn-Hajder JE; Metzger GJ; Lakkadi N; Downs LS; Bolan PJ
    J Magn Reson Imaging; 2013 Dec; 38(6):1501-9. PubMed ID: 23559453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Qualitative (Time Intensity Curve Analysis), Semi-Quantitative, and Quantitative Multi-Phase 3T DCEMRI Parameters as Predictors of Malignancy in Adnexal.
    Malek M; Oghabian Z; Tabibian E; Rahmani M; Miratashi Yazdi SN; Oghabian MA; Parviz S
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1603-1611. PubMed ID: 31244278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-step biomarker quantification methodology for DCE-MRI of adnexal masses: Capturing kinetic pattern from early to late enhancement.
    Fathi Kazerooni A; Nabil M; Haghighat Khah H; Parviz S; Gity M; Saligheh Rad H
    Magn Reson Med; 2018 Feb; 79(2):1165-1171. PubMed ID: 28480550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.